Evidence map›Paper›PMID 30627816›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2019

Cortical atrophic-hypometabolic dissociation in the transition from premanifest to early-stage Huntington's disease.

Frederic Sampedro, Saul Martínez-Horta, Jesús Perez-Perez, Andrea Horta-Barba, Diego Alfonso Lopez-Mora, Valle Camacho, Alejandro Fernández-León, Beatriz Gomez-Anson, Ignasi Carrió, Jaime Kulisevsky

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05769972 (Randomized, Single-blind Clinical Trial to Evaluate the Efficacy of Cognitive Rehabilitation Using Inmersive Virtual Reality and Computer-based Cognitive Stimulation Versus Music Therapy on Cognitive Impairment Associated With Movement Disorders), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05769972 nacompletednot on this mapstarted 2021, after this paper: background citation

Randomized, Single-blind Clinical Trial to Evaluate the Efficacy of Cognitive Rehabilitation Using Inmersive Virtual Reality and Computer-based Cognitive Stimulation Versus Music Therapy on Cognitive Impairment Associated With Movement Disorders

TypeinterventionalSponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauRan2021 to 2023Enrolled64ConditionsParkinson Disease, Huntington DiseaseArmsImmersive Virtual Reality (Parkinson's disease), Computer-based cognitive rehabilitation (Parkinson's disease), Computer-based cognitive rehabilitation (Huntington's disease), Music-therapy (Huntington's disease)
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. [European journal of nuclear medicine and molecular imaging · 2023
    Pooled it
  2. Review
  3. Update on Genetic Chorea.European journal of neurology · 2025
    Review
  4. Cortical changes in the brain of patients with hemifacial spasm.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  5. Mild cognitive impairment in Huntington's disease: challenges and outlooks.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Frederic SampedroMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Mas Casanovas 90, 08041, Barcelona, Spain.
Saul Martínez-HortaMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Mas Casanovas 90, 08041, Barcelona, Spain.
Jesús Perez-PerezMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Mas Casanovas 90, 08041, Barcelona, Spain.
Andrea Horta-BarbaMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Mas Casanovas 90, 08041, Barcelona, Spain.
Diego Alfonso Lopez-MoraNuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Valle CamachoNuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Alejandro Fernández-LeónNuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Beatriz Gomez-AnsonAutonomous University of Barcelona, Barcelona, Spain.
Ignasi CarrióAutonomous University of Barcelona, Barcelona, Spain.
Jaime KulisevskyMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Mas Casanovas 90, 08041, Barcelona, Spain. jkulisevsky@santpau.cat.
Hospital de Sant Pau · ESInstitut d'Investigacions Biomèdiques de Barcelona · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESEuropean Huntington's Disease NetworkUniversitat Autònoma de Barcelona · ES

Funding

Fondo de Investigaciones Sanitarias, Gobierno de España PI17/001885
6 · The paper itself

Abstract

purposeHuntington's disease (HD) is a fatal neurodegenerative disorder with no effective treatment currently available. Although the pathological hallmark of HD is massive striatal atrophy, it has been suggested that cortical deterioration may concomitantly occur and play a major role in the patient's functional independence. Our objective was to characterize cortical structural and metabolic neurodegeneration in the transition from premanifest to early-stage Huntington's disease (HD).

methodsUsing a surface-based neuroimaging approach, we compared cortical thickness and intracortical FDG-PET uptake in 19 early-symptomatic HD patients with respect to 21 premanifest HD individuals.

resultsEarly-HD patients showed significant cortical atrophy and intracortical hypometabolism when compared to premanifest subjects (p < 0.05, corrected for multiple comparisons). However, whereas the atrophy pattern was restricted to precentral and parieto-occipital regions, a pronounced frontotemporal hypometabolism was observed. Importantly, structural changes correlated with motor and cognitive performance, and metabolic changes were associated with the presence and severity of apathy in this population, a core neuropsychiatric feature of this disorder.

conclusionOur findings reveal an asynchronous neuronal loss and metabolic compromise across the cerebral cortex in early HD. Hence, the use of structural and metabolic imaging indicators to characterize disease progression in this population should take into consideration the dissociation which occurs between cortical atrophy and hypometabolism.

Indexed as

Asymptomatic DiseasesDisease ProgressionAdultAtrophyBrainFemaleHumansHuntington DiseaseMagnetic Resonance ImagingMaleMutationPositron Emission Tomography Computed Tomography18F-FDG-PETCortical thicknessHuntington’s diseasePartial volume correction

Identifiers

PMID30627816
OpenAlexW2910582043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.